首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Phosphorylation of Caspase-7 by p21-activated Protein Kinase (PAK) 2 Inhibits Chemotherapeutic Drug-induced Apoptosis of Breast Cancer Cell Lines
【2h】

Phosphorylation of Caspase-7 by p21-activated Protein Kinase (PAK) 2 Inhibits Chemotherapeutic Drug-induced Apoptosis of Breast Cancer Cell Lines

机译:p21激活蛋白激酶(PAK)2磷酸化Caspase-7抑制化学治疗药物诱导的乳腺癌细胞株的凋亡。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

p21-activated kinase (PAK) 2, a member of the PAK family of serine/threonine protein kinases, plays an important role in physiological processes such as motility, survival, mitosis, and apoptosis. However, the role of PAK2 in resistance to chemotherapy is unclear. Here we report that PAK2 is highly expressed in human breast cancer cell lines and human breast invasive carcinoma tissue compared with a human non-tumorigenic mammary epithelial cell line and adjacent normal breast tissue, respectively. Interestingly, we found that PAK2 can bind with caspase-7 and phosphorylate caspase-7 at the Ser-30, Thr-173, and Ser-239 sites. Functionally, the phosphorylation of caspase-7 decreases its activity, thereby inhibiting cellular apoptosis. Our data indicate that highly expressed PAK2 mediates chemotherapeutic resistance in human breast invasive ductal carcinoma by negatively regulating caspase-7 activity.
机译:p21激活激酶(PAK)2是丝氨酸/苏氨酸蛋白激酶PAK家族的成员,在诸如动力,存活,有丝分裂和凋亡等生理过程中起着重要作用。然而,尚不清楚PAK2在抗化学疗法中的作用。在这里我们报道,与人非致瘤性乳腺上皮细胞系和邻近的正常乳腺组织相比,PAK2在人乳腺癌细胞系和人乳腺浸润性癌组织中高表达。有趣的是,我们发现PAK2可以在cer-30,Thr-173和Ser-239位点与caspase-7结合并磷酸化caspase-7。在功能上,胱天蛋白酶7的磷酸化降低其活性,从而抑制细胞凋亡。我们的数据表明,高表达的PAK2通过负调节caspase-7活性介导人乳腺浸润性导管癌的化疗耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号